LifeVantage Corporation Q4 2026 Earnings Recap

Shares declined 3.9% following disappointing revenue trends and signs of continued deceleration, as the company refrained from providing formal guidance and highlighted margin pressures amid a challenging macroeconomic environment.

Key Takeaways

• Fourth quarter net revenue declined 23.1% year-over-year to $42.4 million, weighed down primarily by fewer orders and lower average order size from the active customer base.
• Sales of the MindBody GLP-1 System declined, cycling a strong comparable quarter in fiscal 2025, partially offset by new product LoveBiome introductions.
• Management emphasized the early stage of CEO transition and refrained from issuing formal guidance, citing ongoing business assessments.
• Despite historically strong gross margins (near 80%), concerns remain about translating those economics into sustained growth and profitability under current conditions.
• The company identified brand repositioning and operational improvements as priorities but did not quantify near-term financial impacts.